• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A new high-potency glycine-precipitated antihemophilic factor (AHF) concentrate. Treatment of classical hemophilia and hemophilia with inhibitors.

作者信息

Brinkhous K M, Shanbrom E, Roberts H R, Webster W P, Fekete L, Wagner R H

出版信息

JAMA. 1968 Aug 26;205(9):613-7.

PMID:5695099
Abstract
摘要

相似文献

1
A new high-potency glycine-precipitated antihemophilic factor (AHF) concentrate. Treatment of classical hemophilia and hemophilia with inhibitors.一种新型高效甘氨酸沉淀抗血友病因子（AHF）浓缩剂。用于治疗典型血友病及有抑制剂的血友病。
JAMA. 1968 Aug 26;205(9):613-7.
2
The treatment of classical hemophilia with factor 8 concentrates.
Clin Anesth. 1968;3:288-97.
3
Experimental prophylaxis of severe hemophilia with a factor VIII concentrate.
JAMA. 1969 Jun 9;208(10):1853-6.
4
[The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].用新型抗血友病因子“AHF SRK（人源）”治疗甲型血友病。与抗血友病球蛋白AHG SRK的比较
Schweiz Med Wochenschr. 1971 Dec 18;101(50):1831-8.
5
Acquired circulating anticoagulants in hemophilia A.
N Engl J Med. 1969 Oct 16;281(16):866-73. doi: 10.1056/NEJM196910162811603.
6
Clinical use of a new glycine-precipitated antihemophilic fraction.一种新型甘氨酸沉淀抗血友病因子的临床应用。
Am J Med Sci. 1965 Dec;250(6):643-51. doi: 10.1097/00000441-196512000-00005.
7
Rapid correction of AHF deficiency by antihemophilic factor-method four, with special reference to inhibitors.通过抗血友病因子方法四快速纠正获得性血友病A因子缺乏，特别提及抑制剂
Bibl Haematol. 1970;34:52-9. doi: 10.1159/000384893.
8
Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.经典血友病患者对抗血友病因子浓缩物输注反应的研究。通过促凝血和免疫技术测定的抗血友病因子半衰期的差异。
J Clin Invest. 1972 Oct;51(10):2593-6. doi: 10.1172/JCI107076.
9
Antihemophilic factor concentrate therapy in von Willebrand disease. Dissociation of bleeding-time factor and ristocetin-cofactor activities.血管性血友病中的抗血友病因子浓缩物治疗。出血时间因子与瑞斯托霉素辅因子活性的分离。
JAMA. 1976 Dec 13;236(24):2770-2.
10
Glycine-precipitated antihemophilic factor concentrates and their clinical use.甘氨酸沉淀的抗血友病因子浓缩物及其临床应用。
Thromb Diath Haemorrh Suppl. 1968;35:41-8.

引用本文的文献

1
Gene therapy for haemophilia.血友病的基因治疗。
Cochrane Database Syst Rev. 2020 Apr 28;4(4):CD010822. doi: 10.1002/14651858.CD010822.pub4.
2
Gene therapy for haemophilia.血友病的基因治疗。
Cochrane Database Syst Rev. 2016 Dec 20;12(12):CD010822. doi: 10.1002/14651858.CD010822.pub3.
3
Progress and challenges in the development of a cell-based therapy for hemophilia A.A型血友病细胞疗法开发中的进展与挑战。
J Thromb Haemost. 2014 Dec;12(12):1954-65. doi: 10.1111/jth.12750. Epub 2014 Oct 31.
4
Animal models of hemophilia.血友病动物模型。
Prog Mol Biol Transl Sci. 2012;105:151-209. doi: 10.1016/B978-0-12-394596-9.00006-8.
5
Factor VIII safety: plasma-derived versus recombinant products.凝血因子VIII的安全性：血浆源性产品与重组产品
Blood Transfus. 2011 Oct;9(4):366-70. doi: 10.2450/2011.0092-10. Epub 2011 Apr 12.
6
Current options and new developments in the treatment of haemophilia.血友病治疗的现有选择和新进展。
Drugs. 2011 Feb 12;71(3):305-20. doi: 10.2165/11585340-000000000-00000.
7
Hemophilia: an amazing 35-year journey from the depths of HIV to the threshold of cure.血友病：从深陷艾滋病病毒困境到迈向治愈门槛的35年非凡历程。
Trans Am Clin Climatol Assoc. 2010;121:61-73; discussion 74-5.
8
Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia B.预防 A 型血友病和 B 型血友病犬自发性出血。
Haemophilia. 2010 May;16 Suppl 3(Suppl 3):19-23. doi: 10.1111/j.1365-2516.2010.02255.x.
9
Long-term expression of canine FVIIa in hemophilic dogs.血友病犬体内犬 FVIIa 的长期表达。
Thromb Res. 2010 Apr;125 Suppl 1(Suppl 1):S60-2. doi: 10.1016/j.thromres.2010.01.040. Epub 2010 Feb 10.
10
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.在A型血友病、B型血友病、血管性血友病和因子VII缺乏症的犬类模型中的蛋白质替代疗法和基因转移。
ILAR J. 2009;50(2):144-67. doi: 10.1093/ilar.50.2.144.